Nanoform Q2 FY26 EBITDA loss narrows to EUR 3 million; revenue rises 16% to EUR 0.8 million
Reuters2026/08/20 05:13- Nanoform posted Q2 revenue up 16% to EUR 0.8 million, while EBITDA loss narrowed to EUR 3 million.
- Total operating costs fell 36% to EUR 3.9 million; basic EPS improved to EUR -0.04.
- Cash at June 30, 2026 was EUR 19 million; cash position declined EUR 1.5 million during the quarter.
- Operating free cash flow improved to EUR -3.4 million; employees fell 38% year over year to 108.
- UK MHRA scientific advice supported a hybrid pathway for nanoenzalutamide; first market authorization application targeted before end-2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
30x Token Speed Challenges GPU Dominance! BNP Paribas Praises Cerebras (CBRS.US) CS-4 for Ushering in the "Wafer-Scale + Decoupled Inference" Era
After AI chip company Cerebras Systems held its Supernova Day event on Tuesday, BNP Paribas stated that the partners and related announcements unveiled by the company left a deep impression on them.
South Korea’s Ruling Party Signals No Further Delay to Crypto Tax
Ethereum Exchange Supply Falls 15% as Bitcoin Balances Rise
CENIT completes share rights offering, raises about EUR 10.9 million
Crypto prices
More
